CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in three upcoming investor conferences. Infinity will provide an overview of its business at the following conferences:
- Credit Suisse 2013 Healthcare Conference, Phoenix, AZ, November 13, 2013, 9:00 a.m. MT (11:00 a.m. ET)
- 2013 Deutsche Bank BioFEST, Boston, MA, December 2, 2013, 10:10 a.m. ET
Additionally, on November 21, 2013, Infinity will participate in meetings at RBC Capital Markets’ Denver Healthcare Investor Day in Denver, CO.
Live audio webcasts of Infinity’s presentations at the Credit Suisse and Deutsche Bank conferences will be accessible from the “Investors/Media” section of the company’s website, www.infi.com, and replays will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an
innovative biopharmaceutical company dedicated to discovering,
developing and delivering best-in-class medicines to people with
difficult-to-treat diseases. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. For more information on Infinity,
please refer to the company’s website at www.infi.com.
